MXPA03010181A - Polipeptidos de citocinas. - Google Patents

Polipeptidos de citocinas.

Info

Publication number
MXPA03010181A
MXPA03010181A MXPA03010181A MXPA03010181A MXPA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A
Authority
MX
Mexico
Prior art keywords
methods
polypeptides
imx129840
cytokine
cytokine polypeptides
Prior art date
Application number
MXPA03010181A
Other languages
English (en)
Spanish (es)
Inventor
Peter R Baum
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of MXPA03010181A publication Critical patent/MXPA03010181A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA03010181A 2001-05-10 2002-05-08 Polipeptidos de citocinas. MXPA03010181A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29023901P 2001-05-10 2001-05-10
PCT/US2002/014587 WO2002092762A2 (en) 2001-05-10 2002-05-08 Cytokine polypeptides

Publications (1)

Publication Number Publication Date
MXPA03010181A true MXPA03010181A (es) 2004-03-16

Family

ID=23115104

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010181A MXPA03010181A (es) 2001-05-10 2002-05-08 Polipeptidos de citocinas.

Country Status (8)

Country Link
US (2) US20030104579A1 (enExample)
EP (1) EP1412499A4 (enExample)
JP (1) JP2004535795A (enExample)
AU (1) AU2002314774B2 (enExample)
CA (1) CA2446180A1 (enExample)
MX (1) MXPA03010181A (enExample)
PL (1) PL373008A1 (enExample)
WO (1) WO2002092762A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286128T3 (es) 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.
US7910313B2 (en) 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
WO2002086087A2 (en) * 2001-04-20 2002-10-31 Zymogenetics, Inc. Cytokine protein family
WO2003066002A2 (en) 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
CA2503305A1 (en) 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
JP4808157B2 (ja) 2003-08-07 2011-11-02 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｉｌ−２８およびｉｌ−２９の均一な調製物
AU2005231476B2 (en) 2004-04-02 2011-09-01 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
US7351689B2 (en) 2004-07-29 2008-04-01 Zymogenetics, Inc. Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
US8158129B2 (en) * 2005-04-06 2012-04-17 Ibc Pharmaceuticals, Inc. Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
EP1909821A2 (en) 2005-07-20 2008-04-16 ZymoGenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
US10550171B2 (en) 2012-11-21 2020-02-04 The Governors Of The University Of Alberta Immunomodulatory peptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822082B2 (en) * 2000-06-30 2004-11-23 Zymogenetics, Inc. Polynucleotides for mammalian secreted protein, Z1055G2P
ES2286128T3 (es) * 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.

Also Published As

Publication number Publication date
US20030104579A1 (en) 2003-06-05
AU2002314774B2 (en) 2007-06-28
EP1412499A2 (en) 2004-04-28
US20070081973A1 (en) 2007-04-12
CA2446180A1 (en) 2002-11-21
EP1412499A4 (en) 2005-04-06
WO2002092762A3 (en) 2004-03-04
PL373008A1 (en) 2005-08-08
JP2004535795A (ja) 2004-12-02
WO2002092762A2 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
WO2002092762A3 (en) Cytokine polypeptides
ATE473275T1 (de) Menschliche aminoacyl-trna synthetase polypeptide zur regulation der angiogenese
ATE286053T1 (de) Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
DE60238058D1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
DE69725587D1 (de) Verwendung von wnt polypeptiden
WO2002102997A3 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
SG152273A1 (en) Pdx1 expressing endoderm
WO2005020921A3 (en) C-kit modulators and methods of use
GB2394723A (en) Culture system for rapid expansion of human embryonic stem cells
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
WO2003060082A3 (en) Use of modified pyrimidine compounds to promote stem cell migration and proliferation
WO2004015077A3 (en) Compositions and methods for neural differentiation of embryonic stem cells
EP0559769A4 (en) Heparin binding mitogen with homology to epidermal growth factor (egf)
ATE462782T1 (de) Endothelstammzellen, populationen, isolierungsverfahren und verwendung davon
MXPA04004266A (es) Uso de il-19, il-22 e il-24 para tratar trastornos hematopoyeticos.
WO2004029200A3 (en) Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
WO2021173928A3 (en) Human alpha-galactosidase variants
Fuchigami et al. Fibroblasts promote the collective invasion of ameloblastoma tumor cells in a 3D coculture model
MY207075A (en) Human alpha-galactosidase variants
WO2021226439A3 (en) Engineered relaxins and methods of use thereof
DE60231328D1 (de) Cofilin zur förderung der proliferation und/oder differenzierung hämatopoetischer stammzellen und/oder hämatopoetischer vorläuferzellen
MXPA03008039A (es) Polipeptidos de serpina humanos.
DE50211985D1 (de) Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen
WO2003095614A3 (en) Cytokine polypeptides